• Cellvizio®
    • Overview
    • Education
    • Economics
    • Indications
      • Gastroenterology
        • Barrett’s Esophagus
        • Pancreatic Cysts
        • Gastric Disease
        • Inflammatory Bowel Diseases
        • Irritable Bowel Syndrome – Food Intolerance
        • Bilio-Pancreatic Strictures
        • Colorectal Lesions
      • Pulmonology
        • Lung Nodules
        • Lung Transplant
      • Urology
  • Investors
    • Overview
    • Events and Presentations
    • Financials
    • Governance
  • About Us
    • Our Story
    • Team
      • Board of Directors
      • Leadership Team
    • Join Us
    • Commercial Network
  • Newsroom
    • News
    • Events
    • Press Coverage
  • US
    • INT
    • FR
Mauna Kea touts Cellvizio pancreatic cyst diagnosis data

Mauna Kea touts Cellvizio pancreatic cyst diagnosis data

by Zina | Jul 12, 2017 | Press Coverage

Mauna Kea Technologies today touted the results from a recently published study of its Cellvizio system which supported the use of the device in diagnosing pancreatic cysts.Click to read the full article
Mauna Kea Technologies’ company overview at the JMP Securities 2017 Life Sciences Conference

Mauna Kea Technologies’ company overview at the JMP Securities 2017 Life Sciences Conference

by Zina | Jun 15, 2017 | News

Watch our corporate update with Sacha Loiseau, Ph.D., Founder and CEO presenting Mauna Kea Technologies’ company overview at the JMP Securities 2017 Life Sciences Conference in New York, June 2017  

Mauna Kea Technologies reports full year 2016 financial results and highlights 2017 key priorities

by Zina | May 23, 2017 | News

Click to read
Presentation of New Data Demonstrating the Assessment by Cellvizio of Acute Lung Rejection Following Transplant

Presentation of New Data Demonstrating the Assessment by Cellvizio of Acute Lung Rejection Following Transplant

by Zina | May 23, 2017 | News

Data Presented at the 2017 American Thoracic Society International Conference Paris, May 23, 2017 – 5.45 PM CET – Mauna Kea Technologies (Euronext: MKEA, OTCQX: MKEAY) inventor of Cellvizio®, the multidisciplinary confocal laser endomicroscopy (CLE)...

Strong presence of Cellvizio platform at major medical meetings focused on Gastroenterology

by Zina | May 19, 2017 | News

Click to read more
« Older Entries
Next Entries »

Articles récents

  • ‘Never a Dull Moment’ Dr. Ravi Prakash Keeps Patients Front and Center
  • Mauna Kea Technologies announces results of its Combined General Meeting of June 5, 2025 
  • Mauna Kea Technologies Announces Major AI Breakthrough with Cellvizio in Pancreatic Cystic Lesion Risk Stratification 
  • Mauna Kea Technologies Provides Update on Safeguard Proceedings, Strategic Discussions and Operational Progress 
  • Mauna Kea Technologies announces the availability of preparatory documents for the Combined General Meeting of June 5, 2025 and the instructions for participation 

Commentaires récents

No comments to show.

Company Info

About Us

Join Us

Contact Us

Legal

Legal notice

Privacy policy

Our websites

Cellvizio.net

cell-tolerance.com

Diagnosingbarretts.org

Diagnosingpancreaticcysts.org

Follow us

  • Follow
  • Follow
  • Follow
  • Follow
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}